# FOXD1

## Overview
FOXD1 is a gene that encodes the forkhead box D1 protein, a member of the forkhead family of transcription factors. This protein is characterized by a forkhead or winged-helix DNA-binding domain, which is essential for its role as a transcription factor. The FOXD1 protein is involved in regulating gene expression by binding to specific DNA sequences, thereby influencing various cellular processes, including cell cycle regulation, genomic integrity, and cellular metabolism (Wu2024FOXD1; QuinteroRonderos2018The). It plays a critical role in developmental processes and has been implicated in several pathological conditions, such as reproductive disorders and cancers, including clear cell renal cell carcinoma and basal-like breast cancer (Kumegawa2023FOXD1; Bond2021FOXD1). The protein's interactions with other cellular components, such as those involved in the Wnt signaling pathway, further underscore its significance in cellular signaling and disease progression (Moparthi2022FOX).

## Structure
The FOXD1 protein is a member of the forkhead family of transcription factors, characterized by a forkhead or winged-helix DNA-binding domain (DBD) that is similar to other winged helix proteins. This domain typically consists of about 100 amino acids forming a helix-turn-helix structure, which is crucial for its function as a transcription factor (QuinteroRonderos2018The). The protein comprises 456 amino acids and includes a 122 amino acid-long hyperacidic NH2-terminal domain, which may possess transactivation properties. Additionally, the COOH-terminal domain contains two polyproline runs, which are described as potential effector sites (QuinteroRonderos2018The).

The FOXD1 gene has various GC-rich regions that encode different lengths of homopolymeric polyamino acid stretches. These regions are prone to forming hairpin DNA structures, which can complicate PCR, cloning, and sequencing processes (QuinteroRonderos2018The). While the specific post-translational modifications of FOXD1 are not detailed in the provided context, proteins in this family may undergo modifications such as phosphorylation, which can influence their activity and stability. The context does not provide information on the tertiary or quaternary structures, specific prominent folds, or splice variant isoforms of the FOXD1 protein.

## Function
FOXD1 (forkhead box D1) is a transcription factor that plays a significant role in various molecular processes within healthy human cells. It is primarily active in the nucleus, where it binds to DNA to regulate the transcription of target genes, influencing cellular processes and developmental outcomes (Wu2024FOXD1). FOXD1 is involved in maintaining genomic integrity during mitosis, particularly in clear cell renal cell carcinoma (ccRCC) cells, by ensuring proper chromosome condensation and preventing DNA damage. This function is crucial for DNA damage repair during mitosis, as cells lacking FOXD1 exhibit increased DNA strand breaks and fail to reset chromosomal damage markers after mitosis (Bond2021FOXD1).

FOXD1 also plays a role in cell cycle regulation, particularly in the progression through the G2/M checkpoint and mitosis. It promotes the expression of CDKN1A/p21, which is involved in delaying the G1 to S transition, although its primary impact is observed at the G2/M checkpoint (Bond2021FOXD1). Additionally, FOXD1 influences cellular metabolism by affecting mitochondrial function and glycolysis, suggesting a role in regulating cellular energetics (Bond2021FOXD1). These functions highlight FOXD1's importance in maintaining chromatin stability and promoting proper cell cycle progression.

## Clinical Significance
Mutations and alterations in the FOXD1 gene have been implicated in several reproductive disorders and cancers. In the context of human reproduction, FOXD1 mutations are associated with conditions such as recurrent pregnancy loss (RPL), repeated implantation failure (RIF), intra-uterine growth restriction (IUGR), and preeclampsia (PE). Specific mutations like p.His267Tyr and p.Arg57del have been linked to disturbances in gene transcriptional activity, contributing to these conditions (QuinteroRonderos2019FOXD1).

In cancer, FOXD1 plays a significant role in clear cell renal cell carcinoma (ccRCC) and basal-like breast cancer. In ccRCC, FOXD1 expression is inversely correlated with patient survival, and its inactivation leads to reduced tumor growth and altered cell cycle progression (Bond2021FOXD1). In basal-like breast cancer, FOXD1 is associated with poor prognosis and is involved in maintaining tumor-promoting enhancer-gene programs, which contribute to tumor progression and chemoresistance (Kumegawa2023FOXD1).

These findings suggest that FOXD1 could serve as a potential biomarker and therapeutic target in both reproductive disorders and certain cancers.

## Interactions
FOXD1 is involved in several interactions with proteins and nucleic acids that play a crucial role in various signaling pathways. In breast cancer cells, FOXD1 regulates the expression of the RalA gene by binding to its promoter region, enhancing RalA's GTPase activity and activating the ERK1/2 signaling pathway. This interaction is confirmed through chromatin immunoprecipitation (ChIP) and CUT&Tag-sequencing (Long2022FOXD1dependent). FOXD1 also forms a complex with RalA, ANXA2, and Src, which facilitates the phosphorylation of ANXA2 and further activates the ERK1/2 pathway, promoting circulating tumor cell formation and metastasis (Long2022FOXD1dependent).

In the context of the Wnt signaling pathway, FOXD1 interacts with proteins such as JUNB and ubiquitin/SUMO ligases PIAS4 and TRIM33, which are involved in the regulation of Wnt ligand expression. These interactions suggest that FOXD1 acts as a Wnt pathway activator by promoting Wnt ligand expression (Moparthi2022FOX). Additionally, FOXD1 shares a common interactome with TCF/LEF, key components of the Wnt signaling pathway, and is associated with the histone methyltransferase KMT2A, a regulator of Wnt target gene expression (Moparthi2022FOX).


## References


[1. (QuinteroRonderos2018The) Paula Quintero-Ronderos and Paul Laissue. The multisystemic functions of foxd1 in development and disease. Journal of Molecular Medicine, 96(8):725–739, June 2018. URL: http://dx.doi.org/10.1007/s00109-018-1665-2, doi:10.1007/s00109-018-1665-2. This article has 39 citations.](https://doi.org/10.1007/s00109-018-1665-2)

2. (Moparthi2022FOX) FOX transcription factors are common regulators of Wnt/β-catenin signaling. This article has 0 citations.

[3. (Bond2021FOXD1) Kyle H. Bond, Jennifer L. Fetting, Christine W. Lary, Ivette F. Emery, and Leif Oxburgh. Foxd1 regulates cell division in clear cell renal cell carcinoma. BMC Cancer, March 2021. URL: http://dx.doi.org/10.1186/s12885-021-07957-8, doi:10.1186/s12885-021-07957-8. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-07957-8)

[4. (Wu2024FOXD1) Zheng Wu, Wen Li, Hui Zhu, Shenghu Guo, Yuehua Zhang, Lei Zhang, Xiaojin Guo, Jing Cao, and Zhiyu Wang. Foxd1 promotes proliferation, migration, and epithelial-mesenchymal transformation in esophageal squamous cell carcinoma by targeting snai1. Process Biochemistry, 138:47–56, March 2024. URL: http://dx.doi.org/10.1016/j.procbio.2024.01.006, doi:10.1016/j.procbio.2024.01.006. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.procbio.2024.01.006)

[5. (Long2022FOXD1dependent) Yufei Long, Tuotuo Chong, Xiaoming Lyu, Lujia Chen, Xiaomin Luo, Oluwasijibomi Damola Faleti, Simin Deng, Fei Wang, Mingliang He, Zhipeng Qian, Hongli Zhao, Wenyan Zhou, Xia Guo, Ceshi Chen, and Xin Li. Foxd1-dependent rala-anxa2-src complex promotes ctc formation in breast cancer. Journal of Experimental &amp; Clinical Cancer Research, October 2022. URL: http://dx.doi.org/10.1186/s13046-022-02504-0, doi:10.1186/s13046-022-02504-0. This article has 16 citations.](https://doi.org/10.1186/s13046-022-02504-0)

[6. (Kumegawa2023FOXD1) Kohei Kumegawa, Liying Yang, Kenichi Miyata, and Reo Maruyama. Foxd1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer. Frontiers in Oncology, May 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1156111, doi:10.3389/fonc.2023.1156111. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1156111)

[7. (QuinteroRonderos2019FOXD1) Paula Quintero-Ronderos, Karen Marcela Jiménez, Clara Esteban-Pérez, Diego A. Ojeda, Sandra Bello, Dora Janeth Fonseca, María Alejandra Coronel, Harold Moreno-Ortiz, Diana Carolina Sierra-Díaz, Elkin Lucena, Sandrine Barbaux, Daniel Vaiman, and Paul Laissue. Foxd1 mutations are related to repeated implantation failure, intra-uterine growth restriction and preeclampsia. Molecular Medicine, August 2019. URL: http://dx.doi.org/10.1186/s10020-019-0104-3, doi:10.1186/s10020-019-0104-3. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s10020-019-0104-3)